论文信息 - Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma - 字舞流文

Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma

D. Sidransky | T. Zhao | H. Brem | B. Tyler | I. Suk | N. Skuli | M. Brait | Alexander Perdomo-Pantoja | Wataru Ishida | S. Huq | Arba Cecia | M. Morales | Jayanidhi Kedda | Jeff Ehresman | Yuanxuan Xia | J. Casaos | M. Peters | N. Gorelick | Chenchen Ji | A. Ding | Riccardo Serra | Tianna Zhao | Nicolas Skuli | Noah Gorelick | Joshua Casaos